215 related articles for article (PubMed ID: 15831200)
1. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
Shenoy VS; Vijay IK; Murthy RS
J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles as drug delivery systems.
Manjunath K; Reddy JS; Venkateswarlu V
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
[TBL] [Abstract][Full Text] [Related]
3. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Malam Y; Loizidou M; Seifalian AM
Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
[TBL] [Abstract][Full Text] [Related]
4. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
Constantinides PP; Chaubal MV; Shorr R
Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery to tumours: recent strategies.
Reddy LH
J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
[TBL] [Abstract][Full Text] [Related]
6. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
7. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
Hamad I; Moghimi SM
Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
9. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
Chen ML
Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive liposomes--principle and application in cancer therapy.
Karanth H; Murthy RS
J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630
[TBL] [Abstract][Full Text] [Related]
11. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.
Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868
[TBL] [Abstract][Full Text] [Related]
12. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
Souto EB; Doktorovová S
Methods Enzymol; 2009; 464():105-29. PubMed ID: 19903552
[TBL] [Abstract][Full Text] [Related]
13. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles.
Date AA; Joshi MD; Patravale VB
Adv Drug Deliv Rev; 2007 Jul; 59(6):505-21. PubMed ID: 17574295
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
15. Investigations on 5-fluorouracil solid lipid nanoparticles (SLN) prepared by hot homogenization.
Mao S; Wang P; Bi D
Pharmazie; 2005 Apr; 60(4):273-7. PubMed ID: 15881607
[TBL] [Abstract][Full Text] [Related]
16. Tumour-targeted drug and gene delivery: principles and concepts.
Cassidy J; Schätzlein AG
Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
[TBL] [Abstract][Full Text] [Related]
17. Nano- or submicron-sized liposomes as carriers for drug delivery.
Fang JY
Chang Gung Med J; 2006; 29(4):358-62. PubMed ID: 17051832
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
19. Drug penetration in solid tumours.
Minchinton AI; Tannock IF
Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
[TBL] [Abstract][Full Text] [Related]
20. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]